Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Split – page 2

65 clinical trials in Split, Croatia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Split at a glance
65
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

65 trials in Split

Open in trial search
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:CroatiaCroatia
  • Participants:0–17 years
  • Substances:Vibegron
  • Sponsor:Sumitomo Pharma America Inc.

Myelofibrosis

Recruiting
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sibeprenlimab
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:CroatiaCroatia
  • Participants:65+ years
  • Substances:Epcoritamab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Vedolizumab
  • Sponsor:Odyssey Therapeutics Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Croatian Cooperative Group For Clinical Trial Research In Oncology
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Split

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on autoimmune disorders including trials for new treatments of Sjögren's Syndrome, Systemic Lupus Erythematosus, and Psoriatic Arthritis. Studies are evaluating novel therapeutic approaches to manage symptoms and improve patient outcomes.

  • Systemic Sclerosis Treatment
  • Lupus Nephritis Management
  • Immunological Response Studies
02 Inflammatory Diseases

Comprehensive research into inflammatory conditions, with trials examining treatments for Crohn's Disease and Ulcerative Colitis. Studies are investigating combination therapies and long-term maintenance treatments to improve disease management.

  • Gastrointestinal Disorders
  • Dermatological Conditions
  • Novel Treatment Approaches
03 Neurological Disorders

Advanced clinical trials exploring treatments for Multiple Sclerosis, with studies comparing the efficacy of new medications against established therapies. Research includes both adult and pediatric populations with relapsing-remitting forms of the disease.

  • MS Treatment Innovations
  • Pediatric MS Studies
  • Disease Modification Research
04 Oncology Research

Cutting-edge studies in cancer treatment, including trials for breast cancer and multiple myeloma. Research focuses on targeted therapies and novel treatment combinations to improve patient outcomes.

  • Hematological Malignancies
  • Breast Cancer Therapies
  • Targeted Treatment Approaches
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.